A Randomized, Blinded Study of Two Doses of Novastan® (Brand of Argatroban) Versus Heparin as Adjunctive Therapy to Recombinant Tissue Plasminogen Activator (Accelerated Administration) in Acute Myocardial Infarction: Rationale and Design of the Myocardial Infarction using Novastan® and T-PA (MINT) Study

Author： Jang I-K.   Giugliano R.P.   Massey T.J.   Schwarz Jr. R.P.  

Publisher： Springer Publishing Company

ISSN： 0929-5305

Source： Journal of Thrombosis and Thrombolysis, Vol.5, Iss.1, 1998-01, pp. : 49-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stent implantation in acute myocardial infarction using a heparin-coated stent: a pilot study as a preamble to a randomized trial comparing balloon angioplasty and stenting

By Serruys PW   Grines CL   Stone GW   Garcia E   Kiemeney F   Morice MC   Sousa JE   Hamm C   Costantini C   Probst P   Rutsch W   Penn I   Fernandez-Aviles F   Vandormael M   Bartorelli A   Bilodeau L   Eijgelshoven MHJ  

International Journal of Cardiovascular Interventions, Vol. 1, Iss. 1, 1998-01 ,pp. : 19-27

Informa Healthcare

Access to resources Recommend Favorite

The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): Rationale, Design and Specific Aims

By Grönefeld G.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 447-451

Springer Publishing Company

Access to resources Recommend Favorite

Platelet Activity in the Early Stage of Acute Myocardial Infarction: Relation to Time of Presentation, Treatment with Either Tissue Plasminogen Activator or Streptokinase and Cyclooxygenase Inhibition

By Salvioni Alessandro   Perego Giovanni   Marenzi Giancarlo   Galli Stefano   Assanelli Emilio   Guazzi Maurizio  

Journal of Thrombosis and Thrombolysis, Vol. 5, Iss. 1, 1998-03 ,pp. : 65-71

Springer Publishing Company

Access to resources Recommend Favorite

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study

By Jang Ik-Kyung   Pettigrew Veronica   Picard Michael   Kowey Peter   Demmel Valentin   Zile Michael   Tatsuno Jun   Wackers Frans   Hibberd Mark  

Journal of Thrombosis and Thrombolysis, Vol. 20, Iss. 3, 2005-12 ,pp. : 147-153

Springer Publishing Company

Access to resources Recommend Favorite

Percutaneous Transluminal Coronary Angioplasty versus Thrombolysis in Acute Myocardial Infarction: A Prospective, Matched, Controlled Study

By Hansen Hans-Henrik Tilsted   Thuesen Leif   Rasmussen Klaus   Andersen Henning Rud   Vesterlund Thomas   Villadsen Anton Boel   Schroeder Anne Pauline   Husted Steen Elkjær   Nielsen Torsten Toftegaard  

Scandinavian Cardiovascular Journal, Vol. 34, Iss. 4, 2000-10 ,pp. : 365-370

Informa Healthcare

Access to resources Recommend Favorite